サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1092449

医療用大麻の世界市場規模、シェア、動向分析：製品タイプ別、用途別、地域別のセグメント予測（2022年～2030年）

Medical Marijuana Market Size, Share & Trends Analysis Report By Product Type (Flower, Oil & Tinctures), Application (Chronic Pain, Arthritis, Migraine, Cancer, Diabetes, AIDS, Epilepsy, Parkinson's Disease), Region, & Segment Forecasts, 2022-2030
出版日: | 発行: Grand View Research | ページ情報: 英文 70 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医療用大麻の世界市場規模、シェア、動向分析：製品タイプ別、用途別、地域別のセグメント予測（2022年～2030年）
出版日: 2022年08月01日
発行: Grand View Research
ページ情報: 英文 70 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用大麻の市場規模は、2022年から2030年にかけて21.6％のCAGRで推移し、2030年までに659億米ドルに達すると予測されています。

治療用途での使用が承認される州や国の数が増加していることは、今後数年間の需要を促進する重要な要因の一つです。医療用大麻規制および安全法のようないくつかの規制枠組みの存在は、市場における医薬品の現在の需要指標です。また、ライセンス発行数の増加も、市場を牽引する要因の一つであると考えられています。

当レポートでは、世界の医療用大麻市場を調査し、市場の概要、製品タイプ別・用途別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、範囲

  • 浸透・成長の見通しマッピング
  • 製品パイプライン分析：ステージ別
  • 技術概要
  • 規制枠組み
  • 市場力学
  • 医療用大麻市場分析ツール

第4章 医療用大麻市場の推計と動向分析：製品タイプ別

  • 定義と範囲
  • 医療用大麻市場シェア：製品タイプ別
  • セグメントダッシュボード
  • 花
  • オイル・チンキ

第5章 医療用大麻市場の推計と動向分析：用途別

  • 定義と範囲
  • 医療用大麻市場シェア：用途別
  • セグメントダッシュボード
  • 癌
  • 慢性疼痛
  • うつ病・不安
  • 関節炎
  • 糖尿病
  • 緑内障
  • 片頭痛
  • てんかん
  • 多発性硬化症
  • エイズ
  • 筋萎縮性側索硬化症
  • アルツハイマー病
  • 心的外傷後ストレス障害（PTSD）
  • パーキンソン病
  • トゥレット
  • その他

第6章 医療用大麻市場の推計と動向分析：地域別、製品別

  • 市場規模・予測、動向分析（2017年～2030）

第7章 競合情勢

  • 企業プロファイル
    • Tilray
    • Aurora Cannabis
    • Canopy Growth Corporation
    • Aphria, Inc.
    • Maricann Group, Inc.
    • Tikun Olam, Ltd.
    • MedReleaf. Corp.
    • GW Pharmaceuticals plc.
    • Cannabis Sativa, Inc.
    • Medical Marijuana, Inc.
図表

List of Tables

  • Table 1 U.S. medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 2 U.S. medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 3 Canada medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 4 Canada medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 5 Germany medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 6 Germany medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 7 U.K. medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 8 U.K. medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 9 Italy medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 10 Italy medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 11 Poland medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 12 Poland medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 13 Czech Republic medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 14 Czech Republic medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 15 Switzerland medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 16 Switzerland medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 17 Croatia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 18 Croatia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 19 Netherlands medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 20 Netherlands medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 21 Spain medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 22 Spain medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 23 China medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 24 China medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 25 Japan medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 26 Japan medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 27 India medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 28 India medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 29 Thailand medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 30 Thailand medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 31 Australia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 32 Australia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 33 New Zealand medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 34 New Zealand medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 35 Uruguay medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 36 Uruguay medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 37 Colombia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 38 Colombia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 39 Brazil medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 40 Brazil medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 41 Mexico medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 42 Mexico medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 43 Africa medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 44 Africa medical marijuana market, by Application 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Medical marijuana market variables, trends & scope
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Product Type market share analysis
  • Fig. 14 Segment Dashboard
  • Fig. 15 Flower market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 16 Oil & tinctures market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 17 Application market share analysis
  • Fig. 18 Segment Dashboard
  • Fig. 19 Chronic Pain market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 20 Mental Disorders market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 21 Cancer market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 23 Regional market snapshot
  • Fig. 24 Regional outlook
  • Fig. 25 U.S. Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 26 Canada Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 27 Germany Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 28 U.K. Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 29 Italy Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 30 Poland Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 31 Czech Republic Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 32 Switzerland Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 33 Croatia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 34 Netherlands Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 35 Spain Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 36 China Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 37 Japan Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 38 India Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 39 Thailand Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 40 Australia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 41 New Zealand Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 42 Uruguay Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 43 Colombia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 44 Brazil Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 45 Mexico Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 46 Africa Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-754-4

Medical Marijuana Market Growth & Trends:

The global medical marijuana market size is expected to reach USD 65.8 billion by 2030 and is expected to expand at a CAGR of 21.6% over the forecast period, according to a new report by Grand View Research, Inc. The major factors attributed to the industry growth are the rapid adoption of cannabis in therapeutic applications and a surge in the number of countries legalizing the usage of medical marijuana.

As per numerous studies, cannabis has shown positive results in the treatment of chronic diseases. Thus, with the growing penetration of chronic disease throughout the globe, the industry is expected to see a steep rise in demand. For instance, as per the data released by the WHO, the chronic disease burden was expected to reach 57% by 2020. The growing research and development activities in the industry are also expected to drive the growth in demand.

Additionally, various factors such as a rise in disposable income, increasing social acceptance of cannabis, and growth in awareness regarding the benefits of the product, along with improvements in intellectual property rights of cannabis are some of the major factors that are expected to fuel the growth of the industry.

Key players are coming together on strategic initiatives such as mergers & acquisitions, collaborations, partnerships, funding & investments, and innovative product developments & launches to expand their expertise & product portfolio. This also fuels the industry's growth. For instance, in March 2021, Germany's largest pharmaceutical company, Stada entered the medical marijuana market by launching its two flower products, and further, the company has plans to offer five flower products along with three extracts with different compositions of CBD and THC.

One of the major factors that restrict industry growth is the strict regulation policy. To date, FDA has not allowed the marketing usage of cannabis for the treatment of any disease or condition. Although, the organization has approved one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These permitted drug products are only available with a prescription from a licensed healthcare provider.

Medical Marijuana Market Report Highlights:

  • The market size is anticipated to be valued at USD 65.8 million by 2030, owing to the growing legalization of medical marijuana in various countries
  • In 2021, the oil and tinctures segment dominated the market owing to its growing medical usage for the treatment of chronic pains, cancer, neurological disorders, and others
  • Chronic pain segment dominated in 2021. The growing number of clinical trials with marijuana to treat neuropathic and chronic pain is one of the key indicators, which highlights the rising usage of cannabis in pain management over the coming few years
  • North America dominated in 2021 owing to the presence of major players, the increasing rate of cannabis legalization in the U.S., and the launch of new products

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources & Third Party perspectives
    • 1.3.4 Primary Research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Medical Marijuana Market Outlook, By Revenue (USD Million)

Chapter 3 Medical Marijuana Market Variables, Trends and Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Product Pipeline Analysis, by Stage
  • 3.3 Technology Overview
    • 3.3.1 Technology timeline
  • 3.4 Regulatory Framework
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
    • 3.5.2 Market restraint analysis
  • 3.6 Medical Marijuana Market Analysis Tools
    • 3.6.1 Industry analysis - Porter's
      • 3.6.1.1 Supplier power
      • 3.6.1.2 Buyer power
      • 3.6.1.3 Substitution threat
      • 3.6.1.4 New entrants threat
      • 3.6.1.5 Competitive rivalry
    • 3.6.2 PESTEL Analysis
      • 3.6.2.1 Political landscape
      • 3.6.2.2 Economic landscape
      • 3.6.2.3 Social landscape
      • 3.6.2.4 Technology landscape
    • 3.6.3 Global Marijuana Demand-Supply Analysis
    • 3.6.4 Global Marijuana Trade Route
    • 3.6.5 Patient Pool Analysis

Chapter 4 Medical Marijuana Market: Product Type Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Medical Marijuana Market Share by Product Type
  • 4.3 Segment Dashboard
  • 4.4 Flower
    • 4.4.1 Flower market estimates and forecasts, 2017 - 2030 (USD Million)
  • 4.5 Oil & Tinctures
    • 4.5.1 Oil & tinctures market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 5 Medical Marijuana Market: Application Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Medical Marijuana Market Share by Application
  • 5.3 Segment Dashboard
  • 5.4 Cancer
    • 5.4.1 Cancer market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.5 Chronic Pain
    • 5.5.1 Chronic pain market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.6 Depression & Anxiety
    • 5.6.1 Depression & anxiety market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.7 Arthritis
    • 5.7.1 Arthritis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.8 Diabetes
    • 5.8.1 Diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.9 Glaucoma
    • 5.9.1 Glaucoma market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.10 Migraines
    • 5.10.1 Migraines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.11 Epilepsy
    • 5.11.1 Epilepsy market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.12 Multiple Sclerosis
    • 5.12.1 Multiple Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.13 AIDS
    • 5.13.1 AIDS market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.14 Amyotrophic Lateral Sclerosis
    • 5.14.1 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.15 Alzheimer's Disease
    • 5.15.1 Alzheimer's Disease market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.16 Post-Traumatic Stress Disorder (PTSD)
    • 5.15.1 Post-Traumatic Stress Disorder (PTSD)market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.17 Parkinson's Disease
    • 5.17.1 Parkinson's Disease market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.18 Tourettes
    • 5.18.1 Tourettes market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.19 Others
    • 5.19.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Medical Marijuana Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
    • 6.1.1 U.S.
      • 6.1.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.1.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.2.1 Canada
      • 6.2.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.2.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.3.1 Germany
      • 6.3.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.3.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.4.1 U.K.
      • 6.4.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.4.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.5.1 Italy
      • 6.5.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.5.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.6.1 Poland
      • 6.6.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.6.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.7.1 Czech Republic
      • 6.7.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.7.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.8.1 Switzerland
      • 6.8.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.8.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.9.1 Croatia
      • 6.9.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.9.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.10.1 Netherlands
      • 6.10.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.10.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.11.1 Spain
      • 6.11.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.11.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.12.1 China
      • 6.12.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.12.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.13.1 Japan
      • 6.13.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.13.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.14.1 India
      • 6.14.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.14.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.15.1 Thailand
      • 6.15.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.15.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.16.1 Australia
      • 6.16.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.16.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.17.1 New Zealand
      • 6.17.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.17.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.18.1 Uruguay
      • 6.18.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.18.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.19.1 Colombia
      • 6.19.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.19.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.20.1 Brazil
      • 6.20.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.20.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.21.1 Mexico
      • 6.21.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.21.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.22.1 Africa
      • 6.22.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.22.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 Tilray
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 Aurora Cannabis
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Initiatives
    • 7.1.3 Canopy Growth Corporation
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Aphria, Inc.
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Maricann Group, Inc.
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Tikun Olam, Ltd.
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 MedReleaf. Corp.
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 GW Pharmaceuticals plc.
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives
    • 7.1.9 Cannabis Sativa, Inc.
      • 7.1.9.1 Company Overview
      • 7.1.9.2 Financial Performance
      • 7.1.9.3 Product Benchmarking
      • 7.1.9.4 Strategic Initiatives
    • 7.1.10 Medical Marijuana, Inc.
      • 7.1.10.1 Company Overview
      • 7.1.10.2 Financial Performance
      • 7.1.10.3 Product Benchmarking
      • 7.1.10.4 Strategic Initiatives